Want to track ZEAL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zealand Pharma A/S (ZEAL) Statistics
Valuation metrics
Market Cap -
Enterprise value 19.62B
Trailing P/E (ttm) 3.6
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 2.5
Price/Book (mrq) 1.59
Enterprise Value/Revenue 2.12
Enterprise Value/EBITDA 2.91
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 511.93K
Average volume (90 days) 435.34K
Price summary
52-Week low 233.5
52-Week high 556
Beta -
50-Day moving average 315.02
200-Day moving average 378.57
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.69%
Operating margin 0.74%
Operational effectiveness
Return on assets 0.42%
Return on equity 0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 130.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 90.59
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 204.9
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 37.17%
Book value per share (mrq) 204.92
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
